Update on Measles

Size: px
Start display at page:

Download "Update on Measles"

Transcription

1 Update on Measles Alan R. Hinman, MD, MPH (With thanks to Jim Goodson, Peter Strebel, and Greg Wallace) Texas Immunization Summit November 6, 2014

2 I do not have any relevant conflicts of interest to disclose.

3 Outline of presentation Background on measles US situation Global situation Conclusion

4 Background on measles Aerosol/airborne transmission Rash ~14 days (7-21) after exposure Infectious 4 days prior through 4 days after rash onset Complications in US Diarrhea 8% Otitis media 7-9% Pneumonia 1-6% Encephalitis % Death % SSPE 0.001%

5

6 US annual burden before vaccine ~500,000 cases/yr reported (3-4M actual) 48,000 hospitalizations 4,000 cases encephalitis deaths

7 Evolution of US Measles Program 1962: Challenge to eradicate measles (Langmuir) 1963: 1-dose recommendation (age 9 mos) 1965: 1-dose recommendation (age 12 mos) 1966: 1 st measles elimination goal (Sencer et al) 1967: 1-dose recommendation (age 15 mos) 1978: 2 nd measles elimination goal (Hinman et al) 1989: 2-dose recommendation (age 15 mos & 4-6 yrs*) : measles resurgence 1993: 3 rd measles elimination goal (initiation of VFC) Outbreaks >1 yr ceased 1994: 2 doses (age mos & 4-6 yrs) 2000: Elimination declared * AAP recommended 2 nd dose before middle school entry

8 Number of cases 600, , , , , ,000 Measles Cases, United States 1963 Vaccine Licensed * 30,000 25,000 20,000 15,000 10,000 5, Resurgence nd Dose Recommended 1993 Vaccines for Children Program 2000 Elimination Declared Year *2014 case count preliminary as of August 29

9 Cases/ 100,000 Reported Measles Incidence United States, * Measles elimination declared 1 case/million *2014 case count preliminary as of August 20 Year

10 No of Cases Measles, United States, 2001-Present* Import Non-Import *2014 case count preliminary as of August 29

11 Number of Cases Measles, United States, * Importations by WHO Region Unknown Western Pacific(WPR) South East Asian(SEAR) European(EUR) Eastern Mediterranean(EMR) African(AFR) American(AMR) Year *2014 case count preliminary as of August 29

12 Measles Outbreaks with >20 Cases, United States, * Year Outbreak Name 2014 Knox County State OH (MO) # of Cases 378 Import Status Genotype Setting Imported (Philippines) 2013 Brooklyn NYC 58 Imported (UK) D KC Metro Tippecanoe County DuPage/Cook County MO/KS (TX/NE) IN 34 IL 30 D9 Community Household/ community 44 Imported-virus B3 Community Imported (Romania) Importedvirus D4 D4 Church/ household Homeschool 2014 Manhattan NYC 25 Imported-virus B3 Community Stokes/Orange County Tarrant/Denton County Hennepin County Brooklyn/ Kings County NC 23 Imported (India) D8 Community TX 21 MN 21 NYC 21 Imported (Indonesia) Imported (Kenya) Imported (Israel, Belgium) D9 B3 D4 Church Shelter Community 1st & last rash onsets 3/24/2014 7/23/2014 3/13/2013 6/9/2013 5/5/2014 7/18/2014 5/16/2005-6/24/2005 5/17/2008-7/3/2008 2/11/2014 3/24/2014 4/5/2013 5/7/2013 7/21/2013 8/21/2013 2/15/2011-4/24/2011 2/17/2008-4/25/2008 Duration 18 weeks 13 weeks Median Age 23 y (early) 13 y (late) 10 y (early) 19 mos (late) Age Range 2 wks 53 y 0 mos 32 y 11 weeks 21 y 2 wks 43 y 6 weeks 12 y 9 mos - 49 y 7 weeks 10 y 8 mos - 43 y 6 weeks 22 y 3 mos 63 y 5 weeks 14 y 12 mos -59 y 5 weeks 11 y 4 mos 44 y 10 weeks 23 m 3 mos - 51 y 10 weeks 15 m 5 mos - 11 y *as of August 29, 2014

13 Measles outbreak response has a high economic burden in the U.S. Year Location Number of cases (outbreaks) Estimated public health cost* 2011 US 107 (16) $ M 2011 Utah 13 (2) >$330, California 12 (1) $125, Arizona 14 (1) $800,000 (limited to cost for 2 hospitals to respond to 7 cases in their facilities) 2005 Indiana 34 (1) $168, Iowa 1 $142,000 *Public health and health care costs expended to control the spread of measles

14 Measles U.S. 2014* 594 cases reported from 22 states 50 importations 23 from the Philippines 46 (92%) US residents 98% cases import-associated 66 cases (11%) hospitalized 18 Outbreaks (defined as 3 or more linked cases) Largest outbreak accounts for 2/3 of cases Top 3 outbreaks account for 3/4 of cases Cases in US residents (N=587) 76% unvaccinated 16% unknown vaccination status (mostly adults) 7% vaccinated (including 5% with 2 or more doses) Among unvaccinated 82% were personal belief exemptors 2% unvaccinated travelers age 6 mos 4 yrs 8% too young to be vaccinated * Provisional reports to CDC through September 19, 2014

15 Measles Outbreaks, USA, st onset latest rash 2014 OUTBREAKS State(s) cases Source Genotype PBE 6/11/2014 6/21/2014 New Haven, CT CT 3 Philippines B3 No 5/30/2014 7/3/2014 King Co., WA WA 16 FSM B3 No Clay Co. MO, Johnson Co., KS Sedgwick Co., MO 26, KS 14,TX 2, IV (imp 5/5/2014 7/14/2014 KC Metro NE 1 43 virus) B3 No 4/25/2014 5/11/2014 Hardeman Co. TN 5 Philippines B3 No 3/22/2014 7/23/2014 Knox/Ashland/Holmes/Ric hland,coschocton Cos. OH 376 MO Philippines D9 Yes 3/25/2014 4/9/2014 San Juan Co. WA 7 SE Asia B3 Yes BC 3/15/2014 3/31/2014 Whatcom Co. WA 6 Canada D8 Yes 3/13/2014 3/28/2014 San Mateo Co. CA 3 Philippines B3 No 3/2/2014 3/17/2014 Orange Co. #2 CA 3 IV (imp virus) B3 2/24/2014 3/15/2014 Orange Co. #3 CA 3 IV (imp virus) B3 Yes 2/18/2014 3/7/2014 San Diego CA 4 Philippines B3 No IV (imp 2/11/2014 3/24/2014 Manhattan NYC 25 virus) B3 2/11/2014 3/20/2014 Orange CA #1 CA 11 IV (imp virus) B3 Yes IV (imp 2/4/2014 3/3/2014 Riverside CA 5 virus) B3 Yes 2/8/2014 2/24/2014 Contra Costa CA 3 Philippines B3 Yes 1/24/2014 1/29/2014 (LAX) WI,NYS,TX 3 LAX (1/17) B3 Yes 1/17/2014 2/1/2014 Los Angeles CA 5 Philippines B3 Yes 12/27/2013 1/10/2014 Marion Co. OR 5 China H1 Yes

16 Measles, United States, Jan Sep 19, 2014 Source of Importations (N=50) WHO Region # of cases Countries of travel African 0 Eastern Mediterranean 1 Pakistan European 6 Dubai/Germany/London (1), Republic of Georgia (1), Netherlands (1), France/Belgium (1), Greece (1), Barcelona/Paris (1) Americas 3 Brazil (1), Canada (1), Chile (1) South-East Asia 9 India (7), Indonesia (1), Thailand/South Korea (1) Western Pacific 31 China (4), Philippines (22), Singapore (1), Saipan (1), Vietnam (1), SE Asia/Philippines (1), FSM (1)

17 Ohio Outbreak 2014 Index cases returned from relief work in Philippines Initially worked up for Dengue 377 reported cases (+ 1 case in MO resident) Affected 9 counties (+ 1 MO resident) Largest and longest outbreak in US since resurgence >10,000 vaccine doses administered in response Limited spread outside Knox County Including large Holmes County community (~30,000) No spread to larger Amish community (~275,000 people) No spread outside Amish community

18

19 Global Burden of Measles Prior to Vaccine: 5-8 million deaths/year 77% decrease in incidence from 2000 to % decrease in deaths from 2000 to 2012 (90% since 1985) 122,000 deaths in 2012 (~14 deaths/hour) Remains a leading cause of vaccine preventable deaths in young children Most deaths in children under 5 years old

20

21

22

23 MCV1 coverage among infants by country, 2013 Source: WHO/UNICEF coverage estimates 2013 revision, July WHO Member States. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization Date of slide: 16 July 2014 <50% (4 countries or 2%) 50-79% (33 countries or 17%) 80-89% (28 countries or 14%) >= 90% (129 countries or 66%) Not available Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved

24 Global and Regional MCV2 Coverage New WHO-UNICEF Estimates 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Global Coverage: 53% Source: WHO/UNICEF coverage estimates 2013 revision. July 2014 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of Slide: 17 July 2014 Global AFR AMR EMR EUR SEAR WPR 24

25 Reported Measles Incidence Rate* May 2013 to Apr 2014 (12M period) <1 (83 countries or 43%) 1 - <5 (28 countries or 14%) 5 - <10 (11 countries or 6%) 10 - <50 (43 countries or 22%) 50 (14 countries or 7%) No data reported to WHO HQ Not applicable!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! (15 countries or 8%)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! *Rate per 1'000'000 population Data source: surveillance DEF file Data in HQ as of 10 June 2014

26 Four strategies to reduce measles mortality improve coverage & quality of routine immunization services ensure a second opportunity for measles immunization (supplemental or routine) establish effective surveillance for measles disease and monitoring of vaccine coverage improve case management including Vitamin A supplementation

27 Global Measles and Rubella Laboratory Network: 711 Laboratories in Sub-National Labs N= 690 labs 34 Prov. Labs Prefect. Labs 191/194 countries served by proficient labs National Laboratories Regional Reference Labs Global Specialised Labs Provincial Labs China Sub-National Labs

28

29 Global progress in preventing measles deaths During , 12.7 M measles deaths were averted globally as a result of immunization activities 8.4 M (66%) averted by maintaining routine immunization coverage at 2000 level 4.3 M (33%) averted as a result of Increases in routine immunization coverage Implementation of measles SIAs

30 Estimated Deaths (1000s) 90% Reduction in Estimated Measles Deaths, ,200 1, During % decrease in incidence 78% decline in deaths 13.8 million deaths averted Source: WHO/IVB estimates, February 2014

31

32 No. of deaths "Global Measles Deaths Drop by 78% but Resurgence likely" Estimated number of measles deaths worldwide, and projections of possible resurgence in measles deaths worldwide, Year Estimates* Projected worst case Projected status quo Worst case: MCV1 level, no follow-up SIAs in 47 priority countries Status quo: MCV1 increases and follow-up SIAs continue, no SIAs in India Wkly Epid Rec, 4 december 2009 No. 49, 2009, 84,

33 No. of reported cases (millions) MCV1 Coverage* (%) % Reduction in reported measles cases Measles global annual reported cases and MCV1 coverage*, Number of cases MCV1 Coverage* * MCV1 coverage: coverage with first dose of measles-containing vaccine as estimated by WHO and UNICEF

34

35 44 Measles Campaigns in 33 Countries in million children reached 24 (55%) achieved 95% coverage 36 of 44 SIAs integrated 1 or more other interventions Measles (10) Measles and OPV (11) Measles and Rubella (10) Measles, Rubella and OPV (2) Vitamin A 14 Not Available De-worming 12 Other interventions 5 Not Applicable Updated on 13 March 2014

36 Measles cases by month and year, WHO European Region, Source: MR reporting to WHO European region Update Date : 25-Aug-2014

37 Measles outbreaks in under-vaccinated groups, WHO European Region, Roma and Sinti communities Croatia Bosnia & Herzegovina Bulgaria Greece Italy Poland Romania Spain Followers of Anthroposophy Austria Germany Netherlands Switzerland Sweden Orthodox Protestant communities Netherlands Traveller communities Ireland Norway Spain United Kingdom Ultra-Orthodox Jewish communities Israel Belgium United Kingdom

38 Public settings for reported measles outbreaks, WHO European Region, Schools and educational facilities Health care settings Austria France Germany Ireland Italy Spain Switzerland UK Bulgaria Croatia Czech Republic Denmark France Greece Latvia Italy Netherlands Spain Switzerland

39 Measles Virus (genotype B3) Spread From Philippines to other countries, Confirmed importation Suspected importation MR campaign 9-59m Sept, 2014

40 Too many children still miss out on measles vaccination Iraq, 0.36 Afghanistan, 0.37 USA, 0.38 Philippines, 0.38 Rest of the world, 7.13 DRC, 0.68 Pakistan, 0.74 Indonesia, 1.11 India, 6.37 Nigeria, 2.66 Ethiopia, million infants unimmunized (MCV1), million infants missed MCV1 in % live in India Nigeria Ethiopia Indonesia Pakistan DRC

41

42 Conclusions Measles has been and still is a major killer of children We have effective strategies to prevent measles We just need to implement them fully Measles eradication is inevitable The only question is WHEN we will do it

The State of Measles and Rubella in the WHO European Region

The State of Measles and Rubella in the WHO European Region The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual

More information

Update on Progress and Challenges in Achieving Measles and Rubella Targets

Update on Progress and Challenges in Achieving Measles and Rubella Targets Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets

More information

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California Immunization Coalition, funded through a cooperative agreement

More information

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts Anne Schuchat, MD RADM, US Public Health Service Assistant Surgeon General Director, National Center for Immunization

More information

Measles and Rubella Global Update SAGE 19 October 2017

Measles and Rubella Global Update SAGE 19 October 2017 Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella

More information

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.

More information

Measles 2015: Situational Update, Clinical Guidance, and Vaccination Recommendations

Measles 2015: Situational Update, Clinical Guidance, and Vaccination Recommendations Measles 2015: Situational Update, Clinical Guidance, and Vaccination Recommendations Clinician Outreach and Communication Activity (COCA) Webinar February 19, 2015 Office of Public Health Preparedness

More information

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update November 2018 Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep

More information

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update. April 2018 Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

Measles and Rubella Global Update SAGE April 2018

Measles and Rubella Global Update SAGE April 2018 Measles and Rubella Global Update SAGE April 2018 Alya Dabbagh WHO HQ, IVB/EPI Overview Global update Regional update Surveillance overview M&RI Midterm Review updates Conclusions 2 Measles and Rubella

More information

Global Measles and Rubella Update October 2018

Global Measles and Rubella Update October 2018 Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

宮村参考人提出資料 資料 2-2

宮村参考人提出資料 資料 2-2 宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar

More information

3.1 PHASE 2 OF THE GLOBAL PROJECT

3.1 PHASE 2 OF THE GLOBAL PROJECT RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella

More information

Current Situation on Avian Influenza and the pandemic threat

Current Situation on Avian Influenza and the pandemic threat Vaccine-preventable diseases and Immunization, Communicable Diseases Surveillance and Response Current Situation on Avian Influenza and the pandemic threat IVth Joint EC/ECDC/WHO Workshop on Pandemic Influenza

More information

Selected vaccine introduction status into routine immunization

Selected vaccine introduction status into routine immunization Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF

More information

Epidemiology of measles in infants younger than 6 months: analysis of surveillance data

Epidemiology of measles in infants younger than 6 months: analysis of surveillance data Epidemiology of measles in infants younger than 6 months: analysis of surveillance data 2011-2016 An analysis of the epidemiology of measles in infants younger than 6 months was conducted by the U.S. CDC

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10% % of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected

More information

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej

More information

Global Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva

Global Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global Immunization Overview Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global U5 Mortality: Role of Vaccine Preventable Diseases (2008 data) 8.8 million under five deaths Other 20%

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10% A report on the epidemiology of selected vaccine-preventable diseases in the European Region This report provides an overview of selected epidemiological characteristics of measles and rubella in the WHO

More information

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for

More information

What can be done against XDR-TB?

What can be done against XDR-TB? What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =

More information

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Nigeria Center for Disease Control Federal Ministry of Health Abuja July 2015 Outline 1. Measles disease 2. Progress towards

More information

Drug resistance TB in People Living with HIV: research questions and priorities.

Drug resistance TB in People Living with HIV: research questions and priorities. Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition

More information

Global Polio Eradication & Endgame Strategy. December 2015

Global Polio Eradication & Endgame Strategy. December 2015 Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio

More information

Thank you for joining, the M&RI webinar will begin shortly

Thank you for joining, the M&RI webinar will begin shortly Thank you for joining, the M&RI webinar will begin shortly Please mute your phone or microphone Please do not place the call on hold If you have difficulty with the quality of the connection then here

More information

Immunization Update & focus on meningococcal vaccine PART 1

Immunization Update & focus on meningococcal vaccine PART 1 Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received

More information

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EURO POLIO PAGE Data as of 04 October 2005 (Week 38) World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:

More information

Access to treatment and disease burden

Access to treatment and disease burden Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

Global reductions in measles mortality and the risk of measles resurgence

Global reductions in measles mortality and the risk of measles resurgence Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there

More information

VPD in Mediterranean Basin and Black Sea: the Polio case

VPD in Mediterranean Basin and Black Sea: the Polio case Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio

More information

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist Undetectable = Untransmittable Mariah Wilberg Communications Specialist Undetectable=Untransmittable PLWH who get and stay undetectable have effectively no risk of transmitting HIV to their sex partners

More information

WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI

WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO Rotavirus Vaccine Update 2012 Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO estimates that 453 000 child deaths occurred during 2008 due to rotavirus infection 41057 32653 39144 98621 82% of these deaths occurred

More information

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594 Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%

More information

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and

More information

Global ProhrammeUpdate?

Global ProhrammeUpdate? Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus

More information

Critical immunity thresholds for measles elimination

Critical immunity thresholds for measles elimination Critical immunity thresholds for measles elimination Sebastian Funk Centre for the Mathematical Modelling of Infectious Diseases London School of Hygiene & Tropical Medicine 19 October, 2017!"vöå"!(}å!öZ&!

More information

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region, Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed

More information

Main developments in past 24 hours

Main developments in past 24 hours ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance

More information

Polio Eradication and Surveillance. December

Polio Eradication and Surveillance. December Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication

More information

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever

More information

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution

More information

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007 History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we

More information

Guidance for Travelers on Temporary Work Assignment Abroad

Guidance for Travelers on Temporary Work Assignment Abroad infected person to immediately seek medical care but, prior to arrival, notify their healthcare provider that they may have been exposed to AI. For more information about avian influenza, see www.cdc.gov/flu/avian/facts.htm,

More information

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes

More information

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017 Getting to Zero: On the Verge of Polio Eradication Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine

More information

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017 EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%

More information

Terms and Conditions. VISA Global Customer Assistance Services

Terms and Conditions. VISA Global Customer Assistance Services Terms and Conditions VISA Global Customer Assistance Services Visa Global Customer Assistance Services (VGCAS) 1 The Visa Global Customer Assistance Services are co-ordinated by the Global Assistance Centre

More information

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,

More information

Global EHS Resource Center

Global EHS Resource Center Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research

More information

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand

More information

Vaccine Acceptance, Hesitancy and Refusal

Vaccine Acceptance, Hesitancy and Refusal Nordic Vaccine Meeting Bergen, Norway, 25 April 2014 Vaccine Acceptance, Hesitancy and Refusal Vaccines have prevented countless deaths. So why do some parents hesitate or refuse? Robb Butler Vaccine-preventable

More information

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The

More information

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

Why still Polio Donato Greco ECDC polio consultant 14 April 2016 Why still Polio Donato Greco ECDC polio consultant 14 April 2016 A medical student with the last texbook on Communicable diseases! Where there is no chapter on Poliomielitis!!! What can I say o Background

More information

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States

More information

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015 Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

HPV Vaccines: Background and Current Status

HPV Vaccines: Background and Current Status HPV Vaccines: Background and Current Status Bogota, Colombia, 2007 Jon Kim Andrus, MD HPV and Cervical Cancer Evidence that HPV is essential: Documented molecular studies of cervical cancer Case-control

More information

EUVAC.NET A surveillance network for vaccine-preventable diseases

EUVAC.NET A surveillance network for vaccine-preventable diseases EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention

More information

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/

More information

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Recommended composition of influenza virus vaccines for use in the 2007 influenza season Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

CANCER FACT SHEETS: BREAST CANCER

CANCER FACT SHEETS: BREAST CANCER CANCER FACT SHEETS: BREAST CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO South-East Asia Region More developed regions WHO African Region WHO Region of the

More information

Global landscape analysis and literature review of 2 nd Year of Life immunization platform

Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina

More information

Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch

Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf

More information

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT AUG 3 TO SEPT 5, 215 REPORT WEEK 35 CANADA HUMANS During surveillance week 35, ending on Sept 5, 215, three (3 ) human clinical

More information

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

Hepatitis B vaccination worldwide: Lessons learnt and the way forward Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended

More information

From development to delivery: Decision-making for the introduction of a new vaccine

From development to delivery: Decision-making for the introduction of a new vaccine From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

Methodological issues in the use of anthropometry for evaluation of nutritional status

Methodological issues in the use of anthropometry for evaluation of nutritional status Methodological issues in the use of anthropometry for evaluation of nutritional status Monika Blössner WHO Department of Nutrition for Health and Development Methodological issues in the use of anthropometry?

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

CEO Board report Seth Berkley MD CEO

CEO Board report Seth Berkley MD CEO CEO Board report Seth Berkley MD CEO Dhaka, Bangladesh, 16 17 November 2011 Bangladesh, November 2011 Meningitis Incidence Children < 12 months Dhaka Shishu / Shishu Shahsta Catchment Area 2008 2011 1800

More information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest

More information

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011 Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 Why? Polio Crippled for life Primarily affects children We have a historic opportunity. Preventable with vaccine 1955: polio

More information

European monthly measles monitoring (EMMO)

European monthly measles monitoring (EMMO) SURVEILLANCE REPORT European monthly measles monitoring (EMMO) Issue 9: 19 March 2012 Main developments In January 2012, 584 cases of measles were reported by the 29 contributing EU and EEA countries.

More information

Measles: United States, January 1 through June 10, 2011

Measles: United States, January 1 through June 10, 2011 Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA

More information

Ethics Perspective of Immunisation Programs

Ethics Perspective of Immunisation Programs Ethics Perspective of Immunisation Programs with special reference to Herd Effect T Jacob John Vellore, India Annecy 26 October 2010 Defining Herd immunity and Herd effect. Between participants and nonparticipants

More information

Measles Hysteria: Mark F. Blaxill Health Choice February 20, 2015

Measles Hysteria: Mark F. Blaxill Health Choice February 20, 2015 Measles Hysteria: 2015 Mark F. Blaxill Health Choice February 20, 2015 MEASLES MORTALITY IN THE 20 TH CENTURY Deaths per 100K 16 14 12 10 8 6 4 2 Measles had ceased to be a deadly disease long before the

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB) EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb

More information